The Food and Drug Administration (FDA) announced that it has accepted the New Drug Application (NDA) for UGN-102 for intravesical solution for the treatment of low-grade intermediate-risk non-muscle ...

Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing ...

Nine statements developed, including performing 4 or more versus 3 or fewer needle passes in suspected malignant disease.

Of the about one-third receiving stimulant medication, 71.5% had difficulty filling prescription due to unavailability.

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

In subsequent dose-finding study, numerically greater reductions seen in fatigue, cognitive dysfunction scores with 40 to 45mg/day.

HealthDay News — After Hurricane Helene knocked out a North Carolina production plant for a major supplier of IV fluids for US hospitals, officials said the federal government is reaching out ...

"The swing should never be used for sleep and bedding materials should never be added to it," according to an alert from the US Consumer Product Safety Commission, which announced the recall.

HealthDay News — For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual care, according to a study ...

Nonlinear association seen for effective castration period with metastasis-free survival for any ADT duration.